Skip to main content

Open Data Day spotlight on PhenoPackets

To celebrate Open Data Day 2017, I want to highlight one of the Monarch Initiative’s innovative data sharing tools: the PhenoPacket. At Monarch we playfully refer to the PhenoPacket concept as a “bag of phenotypes” to describe patients. If you aren’t a researcher or clinician, you are probably wondering what a “phenotype” is. A phenotype can be simply defined as the patient signs and symptoms associated with a disease, or more technically defined as the physical manifestation of the combined effects of a person’s genes and their environment. PhenoPackets are a novel way to systematically organize and share the data associated with a patient’s phenotypes.

Currently, data about a patient’s phenotypes is collected by doctors and researchers and can be found in publications, databases, electronic health records, clinical trials, and even social media. This wide variation in data creation leads to diverse data that is not standardized or in a central location, so it is very difficult to see patterns and connections between patients among this data. PhenoPackets were designed to solve these large data integration and computation problems that researchers and clinicians face when collecting or working with phenotype data.

Creating phenotype data that is sharable and standardized allows clinicians and researchers to use this data to improve patient diagnosis. A goal of PhenoPackets is to create data that is more uniform and therefore computationally useful. For a doctor diagnosing a patient, this searchable, comparable phenotype data will allow the clinician to compare their patient to known diseases and other patients around the world, increasing the accuracy of diagnosis. When a patient comes to see their doctor, their PhenoPacket could be created from the phenotypes the doctor sees, and this information could follow the patient to other clinics and could also be published (without personal health information) in journals and databases or even on the Web directly.

What kind of data actually makes up a PhenoPacket? Each patient would have a collection of phenotypes that would be coupled with any available genomic information (e.g. sequencing data), and the data in their PhenoPacket would include: age of onset, symptoms, family history,  and quantitative values related to specific phenotypes, with evidence for each of these categories. The phenotypes are described with common terms using the Human Phenotype Ontology (HPO), allowing for integration of data and computational analysis. The HPO is now incorporated into the Unified Medical Language System (UMLS). Importantly, PhenoPackets do not contain any personal health information, so each patient can remain anonymous in publications or databases. On the technical side, PhenoPackets are encoded in JSON or YAML, but are programming language neutral with implementation tools in several languages. You can read more about the code behind PhenoPackets and try out a tutorial here: https://github.com/phenopackets/phenopacket-format/wiki/Getting-Started

PhenoPackets are supported by the Monarch Initiative and other communities of researchers to aid in disease diagnosis and personalized medicine, as well as model organism research. The creation of more standardized phenotype data that is openly shared amongst researchers and clinicians will lead to more large scale phenotypic data analysis, which can improve patient diagnosis and outcomes and mechanistic discovery.


Read more about the HPO here:

Popular posts from this blog

Finally, a medical terminology that patients, doctors, and machines can all understand.

By Nicole Vasilevsky, Mark Engelstad, Erin Foster, Julie McMurry, Chris Mungall, Peter Robinson, Sebastian Köhler, Melissa Haendel
For many patients with rare and undiagnosed diseases, getting an accurate diagnosis, or even finding the appropriate experts is a long and winding road. To accelerate and facilitate this process, we developed a medical vocabulary (“HPO”) which is comprised of 12,000 terms that doctors can use to codify the precise and distinct observations about patients and their conditions. The HPO is structured in a way that enables machines to intelligently compare a patient’s profile with what scientists worldwide have already uncovered about diseases and their genetic causes.
Until now, most of the HPO labels and synonyms were composed of clinical terms unfamiliar to patients. For example, a patient may know they are ‘color-blind’, but may not be familiar with the clinical term ‘Dyschromatopsia’. This is why we developed a layer of 5,000 corresponding terms that can b…

Why cross-species phenomics informatics is critical to the PMI

Genomics, electronic health records, participant-provided data, sensors, and mobile health technologies can all contribute to personalized medicine. However, we currently cannot achieve statistical correlations amongst these almost unlimited number of parameters that will be collected by the PMI and the depth of mechanistic understanding that will be required for treatment stratification and the development of novel, targeted therapies. The promise of personalized medicine requires deep knowledge of the relationships between genotype, phenotype, and environmental variables - but we simply don’t have enough data. For example, in the ExAC database there are 3,230 genes with near-complete depletion of predicted protein-truncating variants, where 72% of these genes having no currently established human disease phenotype. If we look across organisms, we see that of these 2311 genes with unknown causal phenotypes/diseases, 88% have an associated phenotype in an ortholog, with 56% having or…

Save the Date: Symposium on Linking Disease Model Phenotypes to Human Conditions

Monarch is co-hosting a NIH Symposium titled “Linking Disease Model Phenotypes to Human Conditions” on September 10-11, 2015 at the Fishers Lane Auditorium, NIH, Rockville, MD. 
The purpose of the meeting is to convene a colloquium on the current status of Phenomics and its role in closing the gap that exists between biomedical research and clinical medical practice. The wealth of whole organism, cellular, and molecular data generated in the research laboratory must be translated into clinically relevant knowledge that enables the physician to make the best possible treatment decisions. Phenomics is gaining momentum due to the availability of the complete genomes for many organisms as well as higher throughput methods to genetically modify model organism genomes and observe and record phenotypes. Disease models comprise some of the most important tools of biomedical research. The efficacy of the use of disease models is based upon the principles of evolutionary conservation between sp…